Economic Perspective on Diagnosis and Treatment of Endometriosis
Endometriosis incurs significant societal costs due to diagnostic delays, chronic treatment needs, and lost productivity, underscoring the need for cost-effective diagnostic and treatment research.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (27)
- A cost-effective approach to the management of endometriosis via openalex
- Actuarial Analysis of Private Payer Administrative Claims Data for Women With Endometriosis via openalex
- An economically rational method of managing early-stage endometriosis. via openalex
- Chronic Pelvic Pain: Prevalence, Health-Related Quality of Life, and Economic Correlates via openalex
- Cost comparisons between nafarelin and leuprolide in the treatment of endometriosis via openalex
- Diagnosis and treatment of endometriosis. via openalex
- Diagnostic accuracy of physical examination, transvaginal sonography, rectal endoscopic sonography, and magnetic resonance imaging to diagnose deep infiltrating endometriosis via openalex
- Diagnostic delay in women with pain and endometriosis via openalex
- Economic burden of endometriosis via openalex
- Endometriosis: cost estimates and methodological perspective via openalex
- Endoscopic treatment of endometriosis-associated infertility. Therapeutic, economic and social benefits. via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Evaluation of Lovelace Health Systems chronic pelvic pain protocol. via openalex
- Human issues and medical economics of endometriosis. Three- vs. six-month GnRH-agonist therapy. via openalex
- Is helium thermal coagulator therapy for the treatment of women with minimal to moderate endometriosis cost-effective? A prospective randomised controlled trial via openalex
- Modeling of medical and surgical treatment costs of chronic pelvic pain: new paradigms for making clinical decisions. via openalex
- Modified ultrasound scanning is a cost-effective method for the detection of deep infiltrating endometriosis via openalex
- Pelvic endometriosis: Impact of magnetic resonance imaging on treatment decisions and costs via openalex
- The clinical and economic benefits of GnRH agonist in treating endometriosis. via openalex
- The cost of inpatient endometriosis treatment: an analysis based on the Healthcare Cost and Utilization Project Nationwide Inpatient Sample. via openalex
- The Cost of Treatment of Endometriosis in the California Medicaid Population via openalex
- Time elapsed from onset of symptoms to diagnosis of endometriosis in a cohort study of Brazilian women via openalex
- W6706599912 via openalex
- W2083325871 via openalex
- W2135863583 via openalex
- W3151002452 via openalex
- W6679867864 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00